Personalized medicine is the new horizon of the medical science. Its main goal is to improve the quality of patient care, both in prevention and in therapeutic stage, and to improve the precision of therapy through the integrated analysis of clinical, biological and molecular data. Data integration represents a powerful instrument for clinicians to have an overall vision of diseases. Even if clinical data integration has been treated in many recent papers, few results have been presented with respect to integrating proteomics and genomics data.
Introduction
Patient records contain personal, hospitalization, diagnosis and therapy data, but do not contain genetic or genomic data. However, it is possible, after the extraction of raw data, to obtain information, such as inference, about e.g. familial risk of recurrence, histopathological or molecular classification of tumors, mutations associated with cancer, phenotype molecular, association between families and drug response (pharmacogenomics), identification of biomarkers. Medical records contain unstructured, alphanumeric, diagnostic tests data and textual information from annotations. Furthermore, the majority of clinical data sources are hosted by proprietary commercial software. Data obtained from biological analysis and genomic or genetic studies often present a well-structured formalism, even if often related to a particular software platform. In addition, while basic biological research data sources are open, clinical data sources are kept private with rigorous data access controls, due to the privacy health data regulations. In this scenario data cannot be used for automatic information extraction from the specific software.
We focus on integration between data contained in medical records related to patients with cancer disease, patient's family history and genetic data. Medical records sources may be found in structured or semi-unstructured format, as well as text or PDF files or paper forms. Similarly, genetic information may be found in structured as well as non structured format.
The target of the presented paper is to propose an architecture for data integration for clinical and genetic data. The examples reported are related to genetic information obtained from family tree analysis. Clinical data have to be extracted from heterogeneous sources, finalized to the creation of a local DB repository (semi) structured and displaying data of interest. Data must be stored in a way that can be trusted and preserved, tracking its provenance, and protecting the individual privacy and security. To complete the vision, the data model must be supported by methods for querying, searching, and analyzing data. They must be related to ontological knowledge capable of explaining both genetic and clinical phenomena. After the elaboration of the pedigree containing familial genetic information, thanks to the use of prediction models for computation the genetic risk of carrier mutation, it is possible achieve the knowledge about future cancer risk to improve care process.
Related Works
The importance of integration clinical and genetic/genomic data is documented in [1] where various aspects are highlighted about the clinical-genomic studies and the advantages and disadvantages about application of three different integration methods: early, intermediate and late. Combination between these three methods and several classifiers, to analyse a set of 295 breast cancer samples, for which gene expression data and an extensive set of clinical parameters are available, is carried out in [2] . A scalable informatics framework to combine the use of existing clinical and genomic data for individual patients with diseases having genetic origins is i2b2 (Informatics for Integrating Biology and the Bedside) [31] . i2b2 software shows a hive structure based on a collection of interoperable cells that encapsulates business logic as well as access to data objects behind standard Web interfaces. Analogous to i2b2, the BTRIS (Biomedical Translational Research Information System) system, developed by the US National Institute of Health, combines data from clinical care and clinical research to support several perspectives, including specific, prospective research as well as retrospective re-use of data [42] . In [3] a system that reads, stores, analyses and consolidates sequencing results from multiple technologies, and provides a knowledge base of tumor mutation frequency annotated with clinical significance and drug sensitivity to generate reports for clinicians. Several projects are also documented such as IGV (Integrative Genomics Viewer) and KEGG [4, 5] . The former allows the visualization of heterogeneous data from array-based and next-generation sequencing data sources and phenotypic and clinical context; the [5] is a database that integrates genomic, chemical and systemic functional information, in particular gene catalogs, from completely sequenced genomes, are linked to higher-level systemic functions of the cell, the organism and the ecosystem.
Techniques for information extraction and data analysis has been developed in many applications in the form of unstructured and flat text documents, documents and PDF files and their transformation in a structured form. For instance, in [6] , images obtained from medical documents has been manipulated to extract character strings, converted into text data with an OCR (Optical Character Recognition) engine, then stored into a database. Another approach is represented by the use of NLP (Natural Language Processing) tools and ontologies to extract structured information from clinical text. In [7] the steps of a typical natural language processing to analyse and extract knowledge from clinical text are shown. Ontologies define fundamental concepts, their properties and relations among them within a particular domain.
In the medical domain they are the basic infrastructure to ensure semantic interoperability, where information are integrated and mapped to a common medical vocabulary. An attempt to develop a framework supporting translational research by integrating biomolecular information with patient's clinical data is described in [8] . The framework consists of four levels: (i) a data level, to store the data, (ii) a semantic level, to integrate and standardize the data by the use of ontologies, (iii) an application level, to manage clinical databases, ontologies and data integration process, (iv) a web interface level, to interaction with users.
Ontologies may be identified as supports in information integration. Many ontologies have been developed, each relating to specific biomedical domains. On the NCBO BioPortal [9] there are a number of searchable ontologies, each containing concepts and terms related to resources available for the user to browse. The most mentioned medical ontologies are: UMLS (Unified Medical Language System) [10] , NCI Thesaurus [11] , GALEN (Generalised Architecture for Languages, Encyclopedia and Nomenclature in Medicine) [12] , FMA (Foundational Model of Anatomy) [13] , SNOMED (Systematized Nomenclature of Medicine) [14] , GO (Gene Ontology) [15] , OBO (Open Biomedical Ontology) [16] and Disease Ontology [17] . UMLS integrates key terminology, classification, coding standards and associated resources to promote the creation of more effective and interoperable biomedical information systems, including electronic health records. UMLS Knowledge Sources are represented by: Meta-thesaurus, Semantic Network and the Specialist Lexicon. The Meta-thesaurus is organized by concept, each having a unique and permanent concept identifier. The NCI provides definitions, synonyms, and other information on nearly 10, 000 cancers and related diseases, 8, 000 single agents and combination therapies, and a wide range of other topics related to cancer and biomedical research. GALEN is designed to be a re-usable application-independent and language-independent model of medical concepts. FMA is a domain ontology concerning with the representation of classes or types and relationships necessary for the symbolic representation of the phenotypic structure of the human body in a form which is understandable to humans and also interpretable by machine-based systems. SNOMED CT is a clinical healthcare terminology able to cross-map to other international standard, hence very important for the implementation of electronic health records, containing more than 311, 000 concepts with unique meanings and formal hierarchical logicbased definitions. The Gene Ontology project provides a controlled vocabulary of terms for the description of gene products' characteristics and annotations. The ontology covers three domains: (i) cellular components, (i) molecular functions, and (iii) biological processes. The OBO Foundry is a collaborative experiment involving developers of science-based ontologies working on a set of principles for ontology development with the goal of creating a suite of orthogonal interoperable reference ontologies in the biomedical domain. The Disease Ontology semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI's thesaurus, SNOMED and OMIM. Another diffusely adopted medical vocabulary is MeSH (Medical Subject Headings) [21] . MeSH is the controlled vocabulary thesaurus used for articles indexing on PubMed. It is available online and it is used to quickly locate descriptors of possible interest and to show the hierarchy in which descriptors of interest appear. Therefore the identification of a correspondence between domain concepts from different ontologies and relative concept codes from a system vocabulary appears a key feature, as highlighted in [18] . The importance of medical vocabulary systems to obtain genomic knowledge comes from clinical data has also been described in [19] . A clinical-genomic model in silico is proposed to cluster 635 distinct clinical traits against 12 gene-disease sets obtained by OMIM. Recently, a tool called EMU, able to extract genetic information (e.g. the identification of mutations and associated genes) from biomedical literature has been developed [20] . EMU is used to identify and retrieve mutations from the mutation disease-related corpus with relationship to genes and disease phenotype. An attempt to combine PubMed knowledge and EHR data, in order to develop a cancer risk calculator, is described in [22] .
Integrating EHR with genetic data can give an idea of genotype-phenotype relationships. Examples of integration frameworks between gene expression information and clinical data are give in [23, 24] , in which a statistical prediction tree model combining "metagenes" and clinical risk factors, predicts individual breast recurrence. An approach identifying cancer risk through genetic data is reported in [25] , where by applying machine learning techniques on SNPs data, authors were able to detect the best SNPs predictor. Machine learning techniques allow diagnosis and prognosis improvement of cancer diseases, as reported in [26, 27, 28, 29] .
Genomic-clinical system and databases
The idea underlying this paper is the necessity of integrating genomics information with familiar and clinical information to allow targeted public programs of prevention and early disease detection. This paper indeed is part of the results of a project [43] aiming to model and create a unique platform for clinical and genomic data. The genomic approach involves the identification of all the variants associated to a certain phenotypic trait. This would help to improve the clinical management of patients and counselling for family members. A complete catalogue of genetic variants identified may lead to identify some involved with prognostic aspects of the disease. In order to obtain this correlation, it is necessary to create comprehensive data collections through the creation of a database. The aim is to catalog in one collection all available information: a local DB Repository, based on the use of biomedical ontologies currently available, organizes, optimizes and transforms clinical data to integrate those genomics. The increase in information degree contained in clinical data requires an interaction with information available in literature as well as those available in the local database. Interaction, mediated by Gene Ontology, which can lead to the definition of an "automatic method of extracting" data from the literature to trace the pathology associated with them. Among the major databases containing the association genotype/phenotype we report:
• OMIM, the online mendelian inheritance in human database [34] ;
• Entrez Gene sequences and descriptive information about genetic loci [35] ;
• Gene Cards, a database of genes and their involvement in diseases [36] ;
• HGMD Human Gene Mutation Database, containing information about the disease causative mutations in known genes [37] ;
• dbSNP, the NCBI database on gene variations (Single Nucleotide Polymorphism) [38] .
Disease-specific databases in which molecular changes and associated clinical features are catalogued, are particularly relevant for the correlation of molecular and clinical data. These databases, which already exist for many diseases, are coordinated by Medical Societies and International Scientific Projects and are usually integrated with the main genome browsers (i.e. NCBI, Ensembl, UCSC). They have been built following recommendations and guidelines from specialists in the field. One of the most relevant interest of associating genomic databases with diseases is the one relating cancer and genomics. An example of cancer clinical genomic database, developed on the case-study of brain tumours, is the Repository of Molecular Brain Neoplasia Data (Rembrandt) [33] . It features a web-based data mining and analysis platform through which data can be queried and displayed for both a selected gene and multiple genes. Similarly, the DAVID [39] database allows the analysis of lists of genes, gene annotation and functional classification, as well as the association between diseases and genes. The GALAXY [40] tool allows the creation of workflows through which the user can specify the path followed by raw input data to obtain the desired output, going through intermediate data processing and cleaning tools.
Following the above reported available examples, the idea here is to develop an architecture for information integration regarding clinical and genomic data that uses also web based information.
System Architecture
From the analysis of the state of the art and the problems connected with data extraction from patient records and genomics, we propose an architecture for clinical and genomic data integration and querying. The architecture is reported in Figure 1 . We consider patient EPRs with clinical and genomic data; also, an improvement of cancer risk assessment models is also integrated based on genetic tree predictive algorithms. Knowledge about patient data is organized in an ontology, which is the basis of information extraction, to define cancer risk related to gene mutation. Such an information can be used for clinical strategies (such as monitoring and check frequencies) and it is usually written in the patient record 2.
Data sources extended to the data collected during the annual screening program, to health social network and forum.The development of techniques for the integration of multiple data sources can lead to the interchange between the medical record and genetic/genomic sources and also to include an integration with the Electronic Health Record. In addition, it is possible to develop more accurate predictors based on machine learning techniques, such as artificial neural network or Bayesian network.
The proposed architecture (see Figure 3) is characterized by three different data sources: clinical, laboratory, and those related to genomic databases and medical literature. The first aim is the creation of Meta Health Records (MHR) database (called MetaInfo), where, for a macroscopic research, a few aggregate useful information will be gathered. Useful information are: (i ) Personal (Surname, Name, BirthDate, Sex ) and (ii ) Clinical (Diagnosis, DiagnosisDate, Stage, Therapy, Results, DeathDate).
The MHR will be generated from medical records of each source and share a common identification pattern. Data extraction will be mediated by the biomedical domain ontologies, in order to overcome the problem of diversity in terminology between the sources and the presence of negations in the text. It is possible the application of a system for extracting and querying, where data are enriched with information coming from genetic and familiar oncogenetic counseling process. In addition, data obtained from genetic testing laboratory must be addressed in the database. A second aim is the definition of an architectural component that integrates clinical and genetic clusters, as described above, with a genomic cluster (i.e., genomic databases fused with literature data), called ClinicalGenomic Database.
Architecture's purposes are:
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• Allow to be able to enter information in exchange for information;
• Have an information space wider (Open-Data).
In this context, the actors identified for the system are:
• Clinicians, pharmacologists, biologists, laboratory technicians, who will populate database;
• Patients and technical-administrative users, who can access the ClinicalGenomic Database with different views.
We also identified possible queries, that could benefit from the use of a ClinicalGenomic Database, including: Q1 : For a specific tumor, which genes pattern shows a better survival rate? Q2 : Stratification of a patients group with the same disease, the same molecular profile (mutations cause of the pathology), on the basis of their response to a certain drug treatment; Q3 : Does a specific tumor develop in certain groups (age, ethnicity, geographical area of origin and belonging)? -Example gastric cancer in the Japanese population.
Genetic counseling control in risk estimation: an application
A possible application of the integrated system presented above, based on ClinicalGenomic Database, is represented by the control of genetic counseling and data collection. The purpose of oncology genetic counseling is the overall management of suffering and at risk individuals, • Data collection of family and personal history of the subject, filling of family tree with age and health status of known relatives;
• Verification of clinical data by retrieving medical records about all family cancer cases;
• Computation of risk assessment;
• Delivery of information material to patients and their families and, if indicated, draw a blood sample for the implementation of genetic testing;
• Assessment of the psychological impact by the psychologist.
The genetic test phase regards molecular analysis of patient DNA, to verify the presence of a mutation associated with a high risk of developing a malignancy. The molecular study provides guidance on the possible presence of mutation in the gene of interest, the type of mutation with reference to its presence in the genomic database (e.g. GeneBank) and its presence in disease-specific databases (eg. Breast Cancer Information Core -BIC) [33] .
The post-test consists of:
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• Offer counseling and testing to family members in order to include them in the monitoring plans for high-risk individuals.
Thanks to genetic counseling it will be possible to enrich the ClinicalGenomic database, with data from probands and their families. Genealogical data previously acquired and, if available, genomic data obtained from molecular analysis that have been made, could serve a more accurate reconstruction of a patient's family history of cancer addressed to the counseling process. The risk assessment carried out by using models already available, will benefit from the greater degree of information obtained by the use of ClinicalGenomic Database. In addition, an improvement of risk assessment models, today widely used, is conceivable. The main advantage of the control of counseling resides in the improvement of prevention protocols and screening and, in an indirect manner, in guided choice of therapy.
Conclusions
This paper presents an architecture for clinical and genetica data integration based on ontology. he data model is also able to consider epidemiological studies based on residential or familariaty. We started to recruit data from counseling (anonymized) performed in a south of Italy region to correlate clinical, genomic data to create an instance of a clinicalgenomic database.
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